The U.S. Food and Drug Administration (FDA) has delayed granting full approval of Novavax’s COVID-19 jab.
According to POLITICO, a top FDA official “directly intervened” in an agency review.
Inching very slowly towards the finish line. pic.twitter.com/HT4g202FPX
— Mary Talley Bowden MD (@MdBreathe) April 3, 2025
From POLITICO:
Dr.
Continue reading
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!